Agtc

12085 Research Dr
Alachua, FL 32615

Beacon Therapeutics, an ophthalmic gene therapy company based in Alachua, FL, is dedicated to saving and restoring the vision of patients with prevalent and rare retinal diseases that lead to blindness. Specializing in X-Linked Retinitis Pigmentosa, Dry Age-related Macular Degeneration, and Cone Rod Dystrophy, the company offers pioneering ocular gene therapy through clinical trials and bold AAV Gene Therapy.

With a focus on transforming lives through gene therapy for ophthalmic disorders, Beacon Therapeutics provides hope for lasting treatment and significant vision improvements. Led by Professor Robert MacLaren, the company's mission is to make remarkable happen by delivering innovative solutions for individuals affected by genetic blindness worldwide.

Generated from the website

Own this business?
See a problem?

You might also like